This page includes the latest FDA filings for Y Mabs Therapeutics Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
USA | NASDAQ | YMAB | DUNS 080671180 |
Device Company | Device | Date |
---|---|---|
Y-mAbs Therapeutics, Inc. | Prescription Medication | 2024-04-05 |
Y-mAbs Therapeutics, Inc. | Prescription Medication | 2023-07-19 |
Y-mAbs Therapeutics, Inc. | Prescription Medication | 2022-07-22 |
Y-mAbs Therapeutics, Inc. | Prescription Medication | 2021-01-20 |
Y-MABS THERAPEUTICS INC | 2020-12-02 13:47:39 | |
Y-mAbs Therapeutics, Inc. | DANYELZA | 2020-11-25 |
SEC | 0001722964 | Y-mAbs Therapeutics, Inc. of DELAWARE |
SEC | 1722964 | Y-mAbs Therapeutics, Inc. of DELAWARE |